| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.290 | 1.937 | 24.748 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | 1.298 | 1.971 | 24.748 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 1.382 | 1.841 | 25.511 | 21 | 59 | 15 | 2 | 2 | 790 |
| Gross Profit/Loss - EUR | - | -84 | 130 | -763 | -21 | -59 | -15 | -2 | -2 | -790 |
| Net Profit/Loss - EUR | - | -124 | 70 | -1.506 | -21 | -59 | -15 | -2 | -2 | -790 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Amkor Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 65 | 48 | 0 | 0 | 0 | 0 | 0 | 0 | 181 |
| Current Assets | - | 789 | 1.106 | 27.007 | 25.746 | 25.233 | 24.658 | 24.733 | 24.656 | 2.804 |
| Inventories | - | 572 | 950 | 2.590 | 2.540 | 2.492 | 2.436 | 2.444 | 2.436 | 2.429 |
| Receivables | - | 92 | 107 | 24.358 | 23.149 | 22.710 | 22.206 | 22.275 | 22.208 | 364 |
| Cash | - | 124 | 49 | 59 | 58 | 31 | 16 | 14 | 12 | 12 |
| Shareholders Funds | - | -80 | -8 | -1.513 | -1.505 | -1.535 | -1.516 | -1.522 | -1.520 | -24.385 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 934 | 1.162 | 28.520 | 27.251 | 26.767 | 26.174 | 26.255 | 26.176 | 27.370 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Amkor Medical S.r.l.